Neo Ivy Capital Management Viatris Inc Transaction History
Neo Ivy Capital Management
- $293 Million
- Q1 2025
A detailed history of Neo Ivy Capital Management transactions in Viatris Inc stock. As of the latest transaction made, Neo Ivy Capital Management holds 236,754 shares of VTRS stock, worth $2.1 Million. This represents 0.7% of its overall portfolio holdings.
Number of Shares
236,754Holding current value
$2.1 Million% of portfolio
0.7%Shares
3 transactions
Others Institutions Holding VTRS
# of Institutions
1,136Shares Held
953MCall Options Held
4.15MPut Options Held
2.65M-
Vanguard Group Inc Valley Forge, PA145MShares$1.28 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$822 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD74.5MShares$660 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az64.9MShares$576 Million3.35% of portfolio
-
State Street Corp Boston, MA61.5MShares$545 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $10.8B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...